SCHEMBL4837508

SCHEMBL4837508

O=C1C2CC3C(=O)N(OS(=O)(=O)c4cccc5ccccc45)C(=O)C3CC2C(=O)N1OS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
TSHR P16473 1/20 0.42
HTR6 P50406 3/20 0.41
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
CNR1 P21554 5/20 0.39
MAPT P10636 3/20 0.37
F2 P00734 2/20 0.37
PRSS1 P07477 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4834111 0.87 CA1 (0.46) MEN1KMT2ACA1CA2CA9
SCHEMBL29964496 0.84 MEN1 (0.42) MEN1KMT2ACA1CA2CA9
SCHEMBL547490 0.84 MEN1 (0.42) MEN1KMT2ACA1CA2CA9
SCHEMBL65216 0.81 PARL (0.58) MEN1KMT2ACA1CA2CA9
SCHEMBL5367849 0.79 CA1 (0.47) MEN1KMT2ACA1CA2CA9
SCHEMBL4835127 0.79 TSHR (0.52) MEN1KMT2ACA1CA2CA9
SCHEMBL2900929 0.78 KDM4E (0.57) MEN1KMT2ACA1CA2CA9
SCHEMBL4835319 0.77 KDM4E (0.41) MEN1KMT2ACA2HTR6HTR2A
SCHEMBL4837459 0.76 KMT2A (0.50) MEN1KMT2AF2ALDH1A1PARL
SCHEMBL4837033 0.75 PARL (0.64) MEN1KMT2AMAPTF2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 MEN1 211/4885KMT2A 1016/4885CA1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.